Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

Table 3 Bivariate analysis of LPA and XPT results affected due to mixed MTB infection

	Variable	% participants N = 53		Frequency (n)	LPA/XPT results Affected n (%)	unadjusted OR (95% CI)	P-Values
LPA	Mixed TB infection	No	90.6	48	5/48 (10.4)	1.071 (0.103–11.130)	0.954
LPA	Mixed TB infection	Yes	9.4	5	2/5 (40.0)	1.071 (0.103–11.130)	0.954
XPT	Mixed TB infection	No	90.6	48	2/48 (4.2)	7.556 (0.886–64.445)	0.039*
XPT	Mixed TB infection	Yes	9.4	5	3/5 (60.0)	7.556 (0.886–64.445)	0.039*

LPA Line Probe Assay: XPT Xpert MTB/RIF: OR Odds Ratio: CI Confidence Interval, *adjusted OR was not possible, only one variable met the criteria

ISSN: 1471-2334